Pemazyre 4.5 mg

PEMAZYRE 4.5 MG tablets contain pemigatinib, a medication used for targeted therapy. This oral treatment is designed to interact with specific proteins in the body.

PEMAZYRE 4.5 MG tablets are primarily used for targeted therapy in certain conditions. Pemigatinib works by targeting specific proteins involved in cell growth and division. This medication is often prescribed for conditions where these proteins are overactive, leading to uncontrolled cell growth.

Common effects of PEMAZYRE 4.5 MG tablets may include fatigue, nausea, and changes in hair or skin. Some individuals might experience digestive issues or changes in appetite. These effects can vary widely among users.

PEMAZYRE 4.5 MG tablets should be handled with care. It is important to follow the guidance of a healthcare provider regarding administration and monitoring. Regular check-ups may be necessary to manage potential side effects.

PEMAZYRE 4.5 MG tablets may interact with certain medications, including those that affect liver enzymes. Alcohol and other substances that impact liver function should be discussed with a healthcare provider. Always inform your healthcare provider about all medications you are taking.